Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Wave Life Sciences (WVE) Leases (2016 - 2025)

Wave Life Sciences' Leases history spans 10 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Leases fell 30.29% year-over-year to $12.5 million; the TTM value through Dec 2025 reached $12.5 million, down 30.29%, while the annual FY2025 figure was $12.5 million, 30.29% down from the prior year.
  • Leases reached $12.5 million in Q4 2025 per WVE's latest filing, down from $13.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $27.8 million in Q3 2022 to a low of $12.0 million in Q2 2022.
  • Average Leases over 5 years is $19.1 million, with a median of $18.1 million recorded in 2021.
  • Peak YoY movement for Leases: surged 106.71% in 2023, then tumbled 30.29% in 2025.
  • A 5-year view of Leases shows it stood at $18.4 million in 2021, then surged by 46.06% to $26.8 million in 2022, then dropped by 15.67% to $22.6 million in 2023, then decreased by 21.06% to $17.9 million in 2024, then crashed by 30.29% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Leases are $12.5 million (Q4 2025), $13.9 million (Q3 2025), and $15.2 million (Q2 2025).